May 17th 2024
A recent study showcased at the 2024 ACOG Annual Clinical & Scientific Meeting unveils elinzanetant's efficacy in alleviating vasomotor symptoms, sleep disturbances, and enhancing menopause-related quality of life in postmenopausal women.
23rd Annual International Congress on the Future of Breast Cancer® East
July 19-20, 2024
Register Now!
Community Practice Connections™: 14th Annual International Symposium on Ovarian Cancer and Other Gynecologic Malignancies
View More
4th Annual International Congress on the Future of Women’s Health™
View More
Patient, Provider, and Caregiver Connection™: Exploring Unmet Needs In Postpartum Depression – Making the Case for Early Detection and Novel Treatments
View More
Identifying Health Care Inequities in Screening, Diagnosis, and Trial Access for Breast Cancer Care: Taking Action With Evidence-Based Solutions
View More
16th Annual International Symposium on Ovarian Cancer and Other Gynecologic Malignancies™
May 2025
View More
Alcohol and menopause: A balancing act
July 10th 2023Menopausal women who drink alcohol should limit consumption to moderate drinking, according to experts. However, binge drinking in this population has been on the rise, for which clinicians can help by referring these patients to appropriate treatment.
Read More
Study investigates vaginal estrogen for urinary symptoms of menopause
June 19th 2023Monica Christmas, MD, associate professor at the University of Chicago, discusses the findings of a study on how vaginal estrogen may be used to treat urinary symptoms in postmenopausal women, along with how she hopes these findings will impact treatment in women with urinary symptoms.
Watch
'It's about time,' fezolinetant approval and latest research showcased at annual meeting
May 19th 2023Genevieve Neal-Perry, MD, PhD, talks about the recent approval of fezolinetant (Veozah; Astellas Pharma) and her latest phase 3 research presented at the 2023 ACOG Annual Clinical and Scientific Meeting.
Watch
Hormonal and nonhormonal therapy can improve menopause symptoms
April 14th 2023A literature review found that although hormonal therapy with estrogen is the first-line therapy for bothersome vasomotor symptoms (VMS) and genitourinary syndrome of menopause (GSM) symptoms, nonhormonal medications such as paroxetine and venlafaxine can also be effective for VMS.
Read More
Effects of risk-reducing salpingo-oophorectomy on sexual functioning
April 10th 2023In a recent study, women who received risk-reducing salpingo-oophorectomy when premenopausal more often experienced discomfort during sexual activity and vaginal dryness than those receiving it when postmenopausal.
Read More
The importance of menopause education
March 14th 2023At the International Society for the Study of Women’s Sexual Health conference, held March 2 through 5 in St. Louis, Missouri, Michael Krychman, digital editor for Contemporary OB/GYN® talked with Barb Dehn, NP, from El Camino Women’s Medical Group in Mountain View, California, about the importance of helping professional women cope with menopause.
Read More